Fannie Mori is a seasoned biotech R&D professional with extensive experience in program and portfolio management. They have held leadership roles at companies such as Kronos Bio, Jazz Pharmaceuticals, and Amgen, where they guided cross-functional teams in making strategic decisions. Fannie began their career as an Actuarial Analyst at Watson Wyatt Worldwide before transitioning into biostatistics, culminating in a Master's degree from UCLA. Currently, they serve as Executive Director of Program Management at Avidity Biosciences, Inc.
This person is not in the org chart
This person is not in any teams
This person is not in any offices